NCT03738696View on ClinicalTrials.gov

Liposomal Bupivacaine in Rotator Cuff Repair

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

December 15, 2019

Primary Completion Date

January 1, 2022

Study Completion Date

January 1, 2022

Conditions
Rotator Cuff Injury
Interventions
DRUG

Exparel

A long-acting injectable sodium channel blocker bound to lipid that is indicated in controlling postoperative pain

DRUG

Ropivacaine

A short-acting injectable sodium channel blocker bound to lipid that is indicated in controlling postoperative pain

Trial Locations (1)

35205

UAB Hospital-Highlands, Birmingham

Sponsors
All Listed Sponsors
collaborator

Pacira Pharmaceuticals, Inc

INDUSTRY

lead

University of Alabama at Birmingham

OTHER

NCT03738696 - Liposomal Bupivacaine in Rotator Cuff Repair | Biotech Hunter | Biotech Hunter